Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Financial Ratios
Krebs Biochemicals & Industries Ltd.
BSE Code 524518
ISIN Demat INE268B01013
Book Value (Rs) -63.95
NSE Code KREBSBIO
Dividend Yield % 0.00
Market Cap(Rs Mn) 1695.74
TTM PE(x) 0.00
TTM EPS(Rs) -11.37
Face Value (Rs) 10  
Particulars Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operational & Financial Ratios          
   Earnings Per Share (Rs)-9.15  -11.45  -20.65  -14.45  -16.04  
   CEPS(Rs)-6.01  -8.41  -17.73  -11.84  -13.44  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)-55.29  -46.13  -34.83  -23.91  -18.14  
   Tax Rate(%)0.00  0.00  0.00  0.00  0.00  
Margin Ratios          
   Core EBITDA Margin(%)-17.30  -30.27  -56.94  -32.73  -55.53  
   EBIT Margin(%)-29.83  -41.66  -65.55  -41.12  -68.45  
   Pre Tax Margin(%)-39.13  -47.36  -74.58  -52.81  -86.41  
   PAT Margin (%)-39.13  -47.36  -74.58  -52.81  -86.41  
   Cash Profit Margin (%)-25.71  -34.78  -64.03  -43.27  -72.41  
Performance Ratios          
   ROA(%)-11.17  -13.54  -25.51  -19.36  -20.91  
   ROE(%)0.00  0.00  0.00  0.00  0.00  
   ROCE(%)-18.99  -28.59  -57.38  -40.28  -56.96  
   Asset Turnover(x)0.29  0.29  0.34  0.37  0.24  
   Sales/Fixed Asset(x)0.16  0.18  0.22  0.21  0.14  
   Working Capital/Sales(x)-1.14  -1.58  -1.40  -2.01  -1.38  
Efficiency Ratios          
   Fixed Capital/Sales(x)6.10  5.67  4.60  4.69  7.15  
   Receivable days8.79  4.91  3.60  1.71  17.00  
   Inventory Days78.69  131.30  128.88  107.38  130.87  
   Payable days948.90  378.02  263.51  305.42  507.31  
Valuation Parameters          
   PER(x)0.00  0.00  0.00  0.00  0.00  
   PCE(x)-10.15  -6.71  -8.09  -7.50  -6.09  
   Price/Book(x)-1.10  -1.22  -4.12  -3.72  -4.52  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)6.45  5.85  7.57  5.30  6.39  
   EV/Core EBITDA(x)-39.30  -20.11  -13.77  -16.79  -11.74  
   EV/EBIT(x)-21.62  -14.04  -11.55  -12.90  -9.33  
   EV/CE(x)4.37  3.63  2.38  1.79  1.60  
   M Cap / Sales2.61  2.33  5.18  3.25  4.41  
Growth Ratio          
   Net Sales Growth(%)-3.29  -12.68  11.18  60.72  -30.04  
   Core EBITDA Growth(%)45.43  53.83  -93.68  6.79  -92.84  
   EBIT Growth(%)30.76  44.50  -77.25  3.45  -66.64  
   PAT Growth(%)20.10  44.55  -57.01  1.78  -44.28  
   EPS Growth(%)20.10  44.55  -42.89  9.89  -33.30  
Financial Stability Ratios          
   Total Debt/Equity(x)-1.62  -1.84  -1.91  -2.37  -2.03  
   Current Ratio(x)0.28  0.33  0.45  0.44  0.44  
   Quick Ratio(x)0.12  0.08  0.13  0.10  0.09  
   Interest Cover(x)-3.21  -7.30  -7.26  -3.52  -3.81  
   Total Debt/Mcap(x)1.47  1.51  0.46  0.64  0.45